The company’s technology includes biomaterials used as haemostatic agent for surgery to control bleeding, and miniature electromechanics used in devices for minimally invasive surgeryand biopsy.
FMD distributes its biomaterials products via Ethicon (a division within J&J) through a long-standing mutually exclusive partnership anddistribution agreement dating back to 1995.
FMD was established as a separate legal entity in 2010 through a demerger from Ferrosan A/S. Ferrosan A/S engagement in the haemostatic area dates back to 1947 when the company developed and launched its first product. It is theextensive knowledge of more than 70 years that is the heritage of the company upon which the future is being built.